Pioglitazone raises risk of bladder cancer by 63%

By April 2, 2016arch

A study published in the BMJ (31st March 2016) has found that a drug used to treat Type 2 diabetes, pioglitazone (Actos), may increase the risk of bladder cancer.

Click here to read more

InDependent Diabetes Trust
IDDT